Johnson Thomas, MD, FACE
@JohnsonThomasMD
Endocrinologist. Passionate about thyroid nodules, cancer & AI. Creator of Endo Tools iphone app,TUMScore, AIBx. Tweets ≠ medical advice. Retweets ≠ endorsement
Risk stratify thyroid nodules using artificial intelligence. Find similar images with corresponding diagnosis. Overlay heat maps and make it more explainable to the physician. Increase trust in the predictions. #AI #Thyroid #EndoTwitter #ML #RSNA #TIRADS #medtwitter #XAI #ML4H
🌍 Excited to open up our global evaluation of AI for drug decision-making and therapeutic reasoning @GaoShanghua Want to shape the future of therapeutic AI, from understanding existing medicines to developing new treatments for diseases with limited options? Start here:…
🕒 Register Now to Save! The #atathyroid2025 will be the largest gathering of thyroidologists in the world! 2 weeks left - discounted registration ends 7/30 ow.ly/OhCL50WpPG9 #ThyroidResearch #ThyroidEducation @thyroidjournal @clinicalthyroid
I'm making games with Grok 4 to force myself to work out > do a chin-up, save a cat > push-ups for puppies > planking for penguins coded with Grok 4 (built by @xAI), using mediapipe AI vision and @threejs for animations body movement is tracked in real-time and scores are only…
Read now, Dr. Robenshtok reviews this paper pub’d in #JCEM on how allele frequency of BRAFV600E affects pathologic aggressive & patient outcomes. ow.ly/NC9350WoNjB #medtwitter #endotwitter #thyroid #thyroidcancer @EndoSocJournals
I'm constantly irritated that I don't have time to read the torrent of cool papers coming faster and faster from amazing people in relevant fields. Other scientists have the same issue and have no time to read most of my lengthy conceptual papers either. So whom are we writing…
Google DeepMind released a new series of medical vision LMs 👏 > MedSigLIP: ~900M param CLIP-like model > MedGemma-27B-it: larger MedGemma They have two insane apps for MedGemma, a scan explainer and an agent-agent doctor simulator 🤯
Announcement 📢 We're hiring at @SophontAI for a variety of positions! We're looking for exceptional, high-agency ML research scientists/engineers who are passionate about using AI to build the future of healthcare. Check our website for more details (link in 2nd tweet)
🧬 Excited to open-source Biomni! With just a few lines of code, you can now automate biomedical research with AI agent! We are releasing Biomni A1 (agent) + E1 (env) with 150 specialized tools, 59 databases, and 105 software. E1 is our first attempt at curating the bio-agent…
Excited to launch the public beta of Osler - a workspace + copilot for physicians writing H&P notes that is designed to augment thinking, not replace it. As a resident physician, I built Osler around two core beliefs: 1) the act of writing notes helps doctors think and plan 2)…
Preserving Privacy, Increasing Accessibility, and Reducing Cost: An On-Device Artificial Intelligence Model for Medical Transcription and Note Generation huggingface.co/papers/2507.03…
Good article -> Deep Learning Discovers New Morphological Features while Predicting Genetic Alterations from Histopathology of Papillary #Thyroid Carcinoma #AI liebertpub.com/doi/abs/10.108…
I am deeply honored to receive the 417 Best Doctor Award for Endocrinology. My heartfelt thanks go out to the many physicians, colleagues, and peers who voted for me—your trust and support mean the world to me. #Endocrinology #417 #Springfield #Missouri

Across clinical quality and text similarity, our OnDevice LLM fine-tuned on synthetic data consistently outperforms base models. Sometimes by more than +1.5 points in clinical relevance and +80% in ROUGE scores. ✅ +1.7 ↑ in Completeness ✅ +1.38 ↑ in Overall Quality ✅ +0.56…
medrxiv.org/content/10.110… our article discusses how we curated the data. Generated data is also open sourced.
It’s June & this month’s issue is here to download & read! Find expert reviews on new clinical thyroid research. ow.ly/FpIS50Wkw6S #endotwitter #medtwitter #thyroidcancer #hypothyroidism #hyperthyroidism @AmThyroidAssn @Medscape
Today, @NEJM reports that Efruxifermin (an FGF21 agonist) is the first drug to reduce fibrosis in compensated cirrhosis due to NASH. This effect is seen after 96 weeks, so patience is key. Could combining Semaglutide make it even more powerful?